Black Rock Inc. Xeris Biopharma Holdings, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,332,078 shares of XERS stock, worth $34.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,332,078
Previous 9,960,506
3.73%
Holding current value
$34.9 Million
Previous $22 Million
5.61%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding XERS
# of Institutions
142Shares Held
59.9MCall Options Held
148KPut Options Held
45.7K-
Vanguard Group Inc Valley Forge, PA7.77MShares$26.2 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.3 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$11.8 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.2MShares$10.8 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $460M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...